Overexpression of EZH2, which is the catalytic unit of PRC2, was reported in MYCN-amplified NB [50, 89, 91, 129], potentially silencing genes or networks of genes with a tumor suppressive role. This evidence concerns the gene MYCN and neuroblastoma.